Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants.

O'Brien KL, David AB, Chandran A, Moulton LH, Reid R, Weatherholtz R, Santosham M.

Pediatr Infect Dis J. 2008 Jan;27(1):71-3.

PMID:
18162944
2.

Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.

Clin Infect Dis. 2007 May 1;44(9):1173-9. Epub 2007 Mar 23.

PMID:
17407035
3.

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH; Finnish Otitis Media Study Group.

Clin Infect Dis. 2003 Nov 1;37(9):1155-64. Epub 2003 Oct 7.

PMID:
14557958
4.

Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine.

Millar EV, O'Brien KL, Zell ER, Bronsdon MA, Reid R, Santosham M.

Pediatr Infect Dis J. 2009 Aug;28(8):711-6. doi: 10.1097/INF.0b013e3181a06303.

PMID:
19593248
5.

Pneumococcal disease in United States children: prevalence and treatment.

Clanton M.

Int J Clin Pract Suppl. 2001 Feb;(118):13-21. Review.

PMID:
11715359
6.

Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.

O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, Becenti J, Kvamme S, Whitney CG, Santosham M.

J Infect Dis. 2007 Oct 15;196(8):1211-20. Epub 2007 Sep 17.

PMID:
17955440
7.

Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.

Ekström N, Väkeväinen M, Verho J, Kilpi T, Käyhty H.

Infect Immun. 2007 Apr;75(4):1794-800. Epub 2007 Jan 29.

8.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
9.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.

Clin Infect Dis. 2008 Oct 15;47(8):989-96. doi: 10.1086/591966.

PMID:
18781875
10.

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M.

Lancet. 2003 Aug 2;362(9381):355-61.

PMID:
12907008
11.

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu AA, Käyhty H; FinOM Study Group.

BMC Infect Dis. 2005 May 27;5:41.

12.

Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.

Black S, Shinefield H.

Eur J Pediatr. 2002 Dec;161 Suppl 2:S127-31. Epub 2002 Nov 9.

PMID:
12494258
13.

Brief review of the clinical effectiveness of PREVENAR against otitis media.

Fletcher MA, Fritzell B.

Vaccine. 2007 Mar 22;25(13):2507-12. Epub 2006 Sep 20. Review.

PMID:
17011085
14.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
15.
16.

Impact of the pneumococcal conjugate vaccine on otitis media.

Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P.

Pediatr Infect Dis J. 2003 Jan;22(1):10-6. Erratum in: Pediatr Infect Dis J. 2003 Feb;22(2):163.

PMID:
12544402
17.

Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era.

Marsh RL, Smith-Vaughan H, Beissbarth J, Hare K, Kennedy M, Wigger C, Mellon G, Stubbs E, Gadil JR, Pettit A, Mackenzie G, Tipakalippa P, Morris PS, Leach AJ.

Vaccine. 2007 Mar 22;25(13):2434-6. Epub 2006 Sep 18.

PMID:
17028080
18.

[Pneumococcal conjugate vaccine in children].

Lévy J, Swennen B.

Rev Med Brux. 2004 Sep;25(4):A219-22. French.

PMID:
15516044
19.

Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.

van Heerbeek N, Straetemans M, Wiertsema SP, Ingels KJ, Rijkers GT, Schilder AG, Sanders EA, Zielhuis GA.

Pediatrics. 2006 Mar;117(3):603-8.

PMID:
16510637
20.

Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.

Moulton LH, O'Brien KL, Reid R, Weatherholtz R, Santosham M, Siber GR.

J Biopharm Stat. 2006;16(4):453-62.

PMID:
16892907

Supplemental Content

Support Center